Page last updated: 2024-08-26

nicotine and erlotinib hydrochloride

nicotine has been researched along with erlotinib hydrochloride in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Conte, M; Ellingrod, VL; King, AN; O'Malley, M; Ramnath, N	1
Fujii, A; Harada, T; Hidaka, N; Iwama, E; Kawano, Y; Li, H; Nakanishi, Y; Okamoto, I; Ota, K; Takayama, K; Wang, S	1

Reviews

1 review(s) available for nicotine and erlotinib hydrochloride

Article	Year
Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:7 Topics: Antineoplastic Agents; Camptothecin; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Deoxycytidine; Docetaxel; Enzyme Induction; Erlotinib Hydrochloride; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Neutropenia; Nicotine; Paclitaxel; Polycyclic Aromatic Hydrocarbons; Quinazolines; Smoking; Taxoids	2014

Article

Year

Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014, Volume: 9, Issue:7

Topics: Antineoplastic Agents; Camptothecin; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Deoxycytidine; Docetaxel; Enzyme Induction; Erlotinib Hydrochloride; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Neutropenia; Nicotine; Paclitaxel; Polycyclic Aromatic Hydrocarbons; Quinazolines; Smoking; Taxoids

2014

Other Studies

1 other study(ies) available for nicotine and erlotinib hydrochloride

Article	Year
Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model. Lung cancer (Amsterdam, Netherlands), 2015, Volume: 88, Issue:1 Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Nicotine; Nicotinic Agonists; Receptor Cross-Talk; Receptors, Nicotinic; Smoking; Xenograft Model Antitumor Assays	2015

Article

Year

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model.

Lung cancer (Amsterdam, Netherlands), 2015, Volume: 88, Issue:1

Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Nicotine; Nicotinic Agonists; Receptor Cross-Talk; Receptors, Nicotinic; Smoking; Xenograft Model Antitumor Assays

2015